case_images: PMC10469228_01
case_images: (a) Lung FNA, highly cellular smears from aspirate (Diff Quik stain, low power). (b) Cohesive cluster of malignant cells with pleomorphic nuclei and vacuolated cytoplasm (Diff Quik stain, high power). (c and d) groups of malignant cells with atypical nuclei and vacuolated cytoplasm (H&E stain, low and intermediate power).
case_images: 10.1177_2050313X231196663-fig1.jpg
case_images: PMC10469228_01_10.1177_2050313X231196663-fig1.jpg
case_images: fig1-2050313X231196663
case_images: Biopsies revealed positive malignant cells characteristic of metastatic pulmonary adenocarcinoma at lymph node stations 4, 4 L and 4 R. (Figures 1 and 2).
case_images: Immunohistochemical stains. (a and b) The neoplastic cells display positive cytoplasmic/membranous pankeratin stain (AE1/AE3, intermediate and high power). (c) Napsin A is positive with granular cytoplasmic stain (Napsin A, high power), (d) Thyroid Transcription Factor 1 ( TTF-1) is expressed as strong and diffuse nuclear staining (TTF-1, high power).
case_images: 10.1177_2050313X231196663-fig2.jpg
case_images: PMC10469228_01_10.1177_2050313X231196663-fig2.jpg
case_images: fig2-2050313X231196663
case_images: Biopsies revealed positive malignant cells characteristic of metastatic pulmonary adenocarcinoma at lymph node stations 4, 4 L and 4 R. (Figures 1 and 2).
case_images: (a) Chest CT before Osimertinib initiation. (b) Chest CT 6 months after Osimertinib initiation.. CT, computed tomography.
case_images: 10.1177_2050313X231196663-fig3.jpg
case_images: PMC10469228_01_10.1177_2050313X231196663-fig3.jpg
case_images: fig3-2050313X231196663
case_images: No further new sites of disease were identified (Figure 3(a) and (b)).